Technical Analysis for SVRA - Savara, Inc.
|Grade||Last Price||% Change||Price Change|
SVRA closed up 0.84 percent on Friday, September 22, 2017, on 6.08 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Trend Table & Recent Alerts
|See historical SVRA trend table...|
|Date||Alert Name||Type||% Chg|
|Sep 22||Volume Surge||Other||0.00%|
|Sep 21||Stochastic Reached Overbought||Other||0.84%|
|Sep 20||NR7||Range Contraction||8.03%|
|Sep 20||Calm After Storm||Range Contraction||8.03%|
|Sep 18||Volume Surge||Other||12.49%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Savara Inc., formerly Mast Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor. It is developing Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis, a rare lung disease. AIR001 is a sodium nitrite solution for inhalation via nebulization. AIR001 is in Phase II clinical development for the treatment of heart failure with preserved ejection fraction, also known as diastolic heart failure or heart failure with preserved systolic function.
Is SVRA a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SVRA news...
|52 Week High||16.1|
|52 Week Low||4.6|
|200-Day Moving Average||7.2732|
|50-Day Moving Average||6.3165|
|20-Day Moving Average||7.1298|
|10-Day Moving Average||8.5717|
|Average True Range||0.6359|
|Chandelier Exit (Long, 3 ATRs)||8.0923|
|Chandelier Exit (Short, 3 ATRs)||6.9777|
|Upper Bollinger Band||10.2984|
|Lower Bollinger Band||3.9612|
|Percent B (%b)||0.88|
|MACD Signal Line||0.6886|